Not interested. This amazing company shouldn’t be embarrassed by such lowball attempted takeovers. I would love to ask Prof. Abeyratne what he thinks of this pathetic attempt at stealing this from under us.
Ann: Pfizer raises scheme consideration to A$0.208 per share, page-2
Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #